AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Drug Discovery World Podcast
Where is the latest innovation in neuroscience?
Dec 20, 2023
The podcast covers the latest innovation in neuroscience, including a differentiated approach to developing therapeutics for neurodegenerative diseases, the potential of digital biomarkers to improve drug development, and efforts to enhance technologies for neuroscientists.
37:36
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Oligomerix utilizes a differentiated approach to develop cost-effective, orally administered tau protein inhibitors for neurodegenerative diseases.
- Digital biomarkers offer objective, quantifiable measures for CNS disorders, but the lack of universally accepted biological markers in psychiatric and neurological diseases remains a challenge.
Deep dives
Taking a New Approach to Tackle Neurodegenerative Diseases
Oligomerics, a clinical stage biotechnology company, uses a differentiated approach to develop therapeutics for neurodegenerative diseases. They focus on tau protein inhibitors that can be administered orally and are cost-effective. Their lead candidate, Oligomerics' 07010, has shown promising results in reducing aggregated tau in animal models of neurodegeneration, leading to improved motor activity.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode